Context Therapeutics
Manufacturing · United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.contexttherapeutics.infoRevenue
$100 MillionIndustry
About Context Therapeutics
Context Therapeutics Org Chart
Is Context Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Click to see if Context Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on Context Therapeutics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Context Therapeutics
Product Launch: Get notified when Context Therapeutics launches new products
Check if Context Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Check out if Context Therapeutics is spiking on competitors!
Context Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Context Therapeutics has new funding data
Recommended Actions
Find VP level buyers at Context Therapeutics
Find 2 more new buyers
Company Profile Activity
Activity Insights
Context Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Context Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Context Therapeutics.
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Context Therapeutics
Context Therapeutics is focused on advancing the treatment of female cancers through innovative T cell engaging bispecific antibody therapies. Their clinical-stage pipeline includes CTIM-76, CT-95, and CT-202, which are designed to leverage the immune system for targeted cancer eradication. The company aims to transform cancer care and improve outc... Read More